Deal Corner

DEAL BRIEF

Sequoia Capital India invested Rs. 1 billion in GVK Biosciences Private Limited (GVK BIO), the Hyderabad based leading contract research organization which specializes in pharma and biotech research in the field of medicinal chemistry, informatics, clinical pharmacology and biology . Sequoia Capital India's investment will further empower GVK BIO in expanding its capacity in drug discovery services and providing new services in pre-clinical and clinical space.

OUR ROLE

We, at Nishith Desai Associates, acted as legal counsel for Sequoia Capital India in this investment.